Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Karyopharm Therapeutics I...

    NASDAQ: KPTI · Real-Time Price · USD
    4.87
    -0.29 (-5.53%)
    At close: May 21, 2025, 12:40 PM

    Karyopharm Therapeutics Revenue

    Karyopharm Therapeutics reported an annual revenue of $145.24M, reflecting a -0.55% growth. For the quarter ending March 31, 2025, Karyopharm Therapeutics generated $30.02M in revenue.
    Revenue (ttm)
    $145.24M
    Revenue Growth
    -0.55%
    Price / Sales Ratio
    8.51
    Revenue / Employee
    $520.56K
    Employees
    279
    Market Cap
    42.08M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist